Physician profile
Donald J Egan
NPI 1992772586
$4,665.77
in general payments reported to CMS, 2019-2025
12 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,967 · 2020: $346 · 2021: $188 · 2022: $373 · 2023: $1,087 · 2024: $369 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342 · Consulting Fee: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.23 |
| Consulting Fee | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,838.08 | 2019-2025 | Clariti Contact Lens, Onefit Contact Lens |
| Glaukos Corporation | $868.46 | 2023-2024 | Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem, Ce-Marked Kxla System |
| Alcon Vision LLC | $438.60 | 2019-2025 | Air Optix, Tryptyr |
| Regeneron Healthcare Solutions, INC. | $355.56 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $322.59 | 2019-2025 | Acuvue |
| Allergan, INC. | $263.59 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $260.01 | 2023-2024 | Vyzulta, Lotemax, Miebo |
| Sun Pharmaceutical Industries INC. | $114.34 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $109.76 | 2019 | |
| Lombart Brothers, INC. | $52.63 | 2020 | |
| Abbvie INC. | $28.00 | 2024 | |
| Maculogix, INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.